To date, through the use of proteomic technologies such as for example SEREX, SERPA, ELISA, and proteins microarray, identifying lung cancers circulating autoantibodies and their antigen counterparts shows the potential of bloodstream lab tests develop for detecting early stage lung cancers [11,15,21,31,32]
To date, through the use of proteomic technologies such as for example SEREX, SERPA, ELISA, and proteins microarray, identifying lung cancers circulating autoantibodies and their antigen counterparts shows the potential of bloodstream lab tests develop for detecting early stage lung cancers [11,15,21,31,32]. In this scholarly study, we used phage screen ELISA and strategy Elvitegravir (GS-9137)…
Read more